Skip to content
★ Sign in to follow
BB

Beijing Beilu Pharmaceutical Co., Ltd. Stock: price and insider trades · China

北陆药业

CN·Mcap CN¥4.6BHealth Care

Beijing Beilu Pharmaceutical Co., Ltd.: what insiders have been doing

This page follows insider dealings at Beijing Beilu Pharmaceutical Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Beijing Beilu Pharmaceutical Co., Ltd. has had no insider filing for more than a year; the last one goes back to 3 June 2025.

Since 2021, the database holds no purchases and 7 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€214,666
7 ops. · all time

Who traded when

BuySale
宗利1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 16,367 of 26,912 companies
44.8
score / 100
Value
32
Quality
57
FCF yld-1.4%
Earn yld2.0%
EV/EBITDA20.8x
ROE6.5%
Gross mgn46%
Net mgn7.7%
Debt/EBITDA2.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥7.88
Analyst consensus
·
Income statement
RevenueCN¥1.2B
Gross profitCN¥552.1M46% margin
EBITDACN¥245.6M20% margin
Net incomeCN¥92.7M11.0% margin
Valuation
PER (trailing)31.5x
P/Book1.8x
Beta0.28
Balance sheet & cash
Market capCN¥4.6B
Total debtCN¥516.3M
Free Cash Flow-CN¥62.3M
Debt / Equity21%
Profitability & ownership
ROE6.5%
ROA2.4%
% insiders28.4%
% institutions1.0%
Last declaration on 3 June 2025
Declarations7 total
  • ▼
    董事,高管Executives
    75,378 CNY7SZSE
    10,200 shares4.3% of flowA股XSHESZSE:173000009010905570
  • ▼
    董事,高管Executives
    55,040 CNY7SZSE
    8,000 shares3.3% of flowA股XSHESZSE:173000006953700030
  • ▼
    董事,高管Executives
    151,200 CNY8SZSE
    20,000 shares9.3% of flowA股XSHESZSE:173000006628185470
  • ▼
    董事,高管Executives
    48,000 CNY7SZSE
    5,000 shares2.9% of flowA股XSHESZSE:173000004832115900
  • ▼
    董事,高管Executives
    94,900 CNY8SZSE
    10,000 shares5.8% of flowA股XSHESZSE:173000004832115940
  • ▼
    董事Executives
    620,400 CNY11SZSE
    60,000 shares37.0% of flowA股XSHESZSE:173000004706551200
  • ▼
    董事Executives
    625,800 CNY11SZSE
    60,000 shares37.3% of flowA股XSHESZSE:173000004706551230

7 of 7 declarations

About Beijing Beilu Pharmaceutical Co., Ltd.

北陆药业 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medicines.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations